|
Market Closed -
Euronext Paris
20:55:00 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.256 EUR | +0.32% |
|
0.00% | -21.60% |
| 11-06 | Innate Pharma S.A., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-05 | Innate Pharma provides clinical and financial update |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPH | Real-time | |
CBOE
| IPHp | Real-time | |
Börse Stuttgart
| IDD | Delayed | |
OTC Markets
| IPHYF | Delayed | |
Deutsche Boerse AG
| IDD | Delayed | |
Xetra
| IDD | Delayed | |
London S.E.
| 0EVI | Delayed | |
CBOE
| 0EVI | Real-time | |
Tradegate
| IDD | Real-time | |
Boerse Muenchen
| IDD | Real-time | |
Borsa Italiana
| 4IPH | End-of-day quote | |
Nasdaq
| INNTY | Delayed | |
CBOE
| INNTY | Real-time | |
Deutsche Boerse AG
| IDDA | Delayed | |
Boerse Muenchen
| IDDA | Real-time | |
Börse Stuttgart
| IDDA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 1.286 | 1.61 | 1.908 |
| Spread/Res. | -2.33% | -21.99% | -34.17% |
| Spread/Supp. | +5.19% | +5.19% | +16.95% |
| Support | 1.194 | 1.194 | 1.074 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IPH Stock
- Charts Innate Pharma
Select your edition
All financial news and data tailored to specific country editions

















